Indoco Remedies Limited announced that its Goa Plant-II & III retained the “Official Action Indicated” (OAI) status following a July 2024 inspection by the U.S. FDA. The facility had received OAI in May 2023 after an earlier inspection, with ongoing remedial actions expected to be completed by Q3 2024. Indoco remains committed to meeting regulatory expectations and ensuring high-quality standards in its products. The company is actively working on resolving compliance issues.
